All In Biotech

Free tool

FAERS Monitor: Paclitaxel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216338 or its brand name (Paclitaxel, Paclitaxel). Reports on generic versions are filed under their own applications.

Reports

84,326

Serious

81,765

97% of reports

Hospitalization

34,078

Death reported

11,621

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea4,733
  • dyspnoea4,676
  • neutropenia4,628
  • off label use4,561
  • diarrhoea4,383
  • anaemia4,036
  • malignant neoplasm progression3,938
  • myelosuppression3,678
  • disease progression3,478
  • fatigue3,475
  • neuropathy peripheral3,433
  • pyrexia3,235
  • vomiting3,198
  • febrile neutropenia3,176
  • drug ineffective2,641

Reports by year received

View as table
YearReports
2004626
2005832
2006599
2007576
2008812
2009968
2010990
20111,649
20122,062
20132,215
20141,795
20152,370
20162,931
20173,194
20184,835
20194,669
20204,850
20215,551
20227,668
20238,071
20249,609
202510,146
20267,307

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,969,833 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal3,67828.327.386,940
febrile neutropeniaSignal3,17612.512.132,060
malignant neoplasm progressionSignal3,9389.99.630,567
neuropathy peripheralSignal3,4339.39.024,619
neutropeniaSignal4,6288.88.530,895
disease progressionSignal3,4787.57.319,195
anaemiaSignal4,0365.45.214,176
pyrexiaSignal3,2352.32.32,511
dyspnoeaSignal4,6762.12.02,631
vomiting3,1981.71.6938
diarrhoea4,3831.71.61,289
nausea4,7331.51.5799
off label use4,5611.31.3329
fatigue3,4751.11.142
drug ineffective2,6410.50.51,415

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.